NK:IO
NK:IO is an immunotherapy for the treatment of cancer founded in 2020.
1
Funding Rounds
$1.5m
Money raised
Overview
NK:IO is an immunotherapy for the treatment of cancer founded in 2020.
- Website:
- Business model: B2C
- Headquarters: London
Funding series
Funding Series Analysis
The company NK:IO has raised a total of $1.5m in funding over 1 rounds.
Key Insights:
- NK:IO July 2023 Seed Funding Round: $1.5m
NK:IO July 2023 Seed Funding Round
$1.5m